1. Home
  2. FTK vs ACET Comparison

FTK vs ACET Comparison

Compare FTK & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$16.26

Market Cap

445.8M

Sector

Industrials

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.51

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTK
ACET
Founded
1985
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
445.8M
71.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FTK
ACET
Price
$16.26
$0.51
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$16.00
$8.50
AVG Volume (30 Days)
316.9K
2.9M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
242.12
N/A
EPS
0.93
N/A
Revenue
$220,501,000.00
N/A
Revenue This Year
$20.33
N/A
Revenue Next Year
$12.59
N/A
P/E Ratio
$17.51
N/A
Revenue Growth
23.56
N/A
52 Week Low
$6.05
$0.45
52 Week High
$18.96
$1.11

Technical Indicators

Market Signals
Indicator
FTK
ACET
Relative Strength Index (RSI) 56.29 36.30
Support Level $15.01 $0.46
Resistance Level $16.98 $0.59
Average True Range (ATR) 0.83 0.04
MACD 0.03 0.00
Stochastic Oscillator 71.91 21.32

Price Performance

Historical Comparison
FTK
ACET

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: